EVELO BIOSCIENCES INC's ticker is EVLO and the CUSIP is 299734103. A total of 63 filers reported holding EVELO BIOSCIENCES INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $98,000 | -32.4% | 28,825 | +20.4% | 0.00% | – |
| Q4 2021 | $145,000 | -12.7% | 23,945 | +1.3% | 0.00% | – |
| Q3 2021 | $166,000 | -46.6% | 23,632 | +4.5% | 0.00% | – |
| Q2 2021 | $311,000 | +48.1% | 22,618 | +15.4% | 0.00% | – |
| Q1 2021 | $210,000 | -10.3% | 19,603 | +1.1% | 0.00% | – |
| Q4 2020 | $234,000 | +157.1% | 19,384 | +12.7% | 0.00% | – |
| Q3 2020 | $91,000 | +4.6% | 17,194 | -3.3% | 0.00% | – |
| Q2 2020 | $87,000 | +14.5% | 17,784 | -12.5% | 0.00% | – |
| Q1 2020 | $76,000 | -8.4% | 20,328 | 0.0% | 0.00% | – |
| Q4 2019 | $83,000 | -32.0% | 20,328 | +1.4% | 0.00% | – |
| Q3 2019 | $122,000 | -26.9% | 20,048 | +7.7% | 0.00% | – |
| Q2 2019 | $167,000 | +36.9% | 18,619 | +22.5% | 0.00% | – |
| Q1 2019 | $122,000 | – | 15,198 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARBOURVEST PARTNERS LLC | 3,063,505 | $37,038,000 | 14.47% |
| Mayo Clinic | 484,953 | $5,863,000 | 7.05% |
| Flagship Pioneering Inc. | 22,900,069 | $276,862,000 | 5.04% |
| Trustees of Columbia University in the City of New York | 113,850 | $1,376,000 | 1.84% |
| Alphabet Inc. | 1,060,495 | $12,821,000 | 0.62% |
| Artal Group S.A. | 700,000 | $8,463,000 | 0.18% |
| Larson Financial Group LLC | 28,353 | $343,000 | 0.12% |
| PEDDOCK CAPITAL ADVISORS, LLC | 3,663 | $44,000 | 0.02% |
| CREDIT SUISSE AG/ | 2,705,511 | $32,710,000 | 0.02% |
| FMR LLC | 6,803,365 | $82,253,000 | 0.01% |